|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.101 SEK | +2.02% |
|
+1.00% | +78.45% |
| 04-24 | Perpetua Medical AB Appoints Camilla Lonn as CFO | CI |
| 04-23 | Pharmacolog i Uppsala AB will Change its Ticker to PERP B from PHLOG B | CI |
Pharmacolog i Uppsala AB (publ) reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was SEK 9.94 million compared to SEK 10.11 million a year ago. Revenue was SEK 9.98 million compared to SEK 10.42 million a year ago.
Net loss was SEK 18.28 million compared to SEK 19.16 million a year ago. Basic loss per share from continuing operations was SEK 0.44 compared to SEK 1.17 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +78.45% | 1.01M | |
| -19.18% | 19.69B | |
| -39.00% | 3.01B | |
| +22.02% | 1.94B | |
| -0.62% | 1.66B | |
| +35.53% | 1.34B | |
| -22.01% | 895M | |
| +7.00% | 827M | |
| -23.80% | 638M | |
| +10.85% | 516M |
PHARMACOLOG I UPPSALA AB 
